{"filing":{"accession_number":"0001213900-26-103071","cik":"0001837821","ticker":"ZJYL","company_name":"Jin Medical International Ltd.","form":"6-K","filing_date":"2026-09-24","report_date":"2026-09-24","primary_document":"ea0306176-6k_jinmed.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1837821/000121390026103071/ea0306176-6k_jinmed.htm"},"events":[{"id":34924,"run_id":32155,"accession_number":"0001213900-26-103071","anchor_item_number":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"The 6-K discloses completion of a material acquisition on September 24, 2026, whereby Jin Medical obtained contractual control over Huaxia Qiying (Beijing) Technology Co., Ltd. through VIE arrangements for an aggregate purchase price of US$159.4 million, consisting of 71.3 million Class A shares plus non-share consideration. This is a completed change-of-control transaction meeting the definition of ma_activity under Item 1.01/2.01.","company_name":"Jin Medical International Ltd.","ticker":"ZJYL","filing_date":"2026-09-24","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":38804,"accession_number":"0001213900-26-103071","item_number":null,"item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The 6-K discloses completion of a material acquisition on September 24, 2026, whereby Jin Medical obtained contractual control over Huaxia Qiying (Beijing) Technology Co., Ltd. through VIE arrangements for an aggregate purchase price of US$159.4 million, consisting of 71.3 million Class A shares plus non-share consideration. This is a completed change-of-control transaction meeting the definition of ma_activity under Item 1.01/2.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-24T20:34:49.787782+00:00","company_name":"Jin Medical International Ltd.","ticker":"ZJYL","filing_date":"2026-09-24"}]}